Clinical Trials Directory

Trials / Unknown

UnknownNCT03364257

iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients

National, Single-arm Clinical Study on iDTECT™ Blood Performance to Identify Viral or Bacterial Pathogens in Febrile Neutropenic Patients With Suspected Infection

Status
Unknown
Phase
Study type
Observational
Enrollment
97 (estimated)
Sponsor
Pathoquest · Industry
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

Prospective, multicentre French observational study assessing the performance and medico-economic utility of iDTECT Blood versus conventional microbiologic diagnosis in patients with febrile neutropenia

Detailed description

Febrile neutropenic patients suspected of sepsis will follow the conventional infectious diagnosis work-up over the entire observation period, and will be tested in addition with iDTECT Blood on Study Day 1.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTiDTECT BloodNext generation sequencing-based shot-gun metagenomic test for the diagnosis of viral or bacterial infections using blood samples

Timeline

Start date
2018-05-18
Primary completion
2019-04-30
Completion
2019-05-31
First posted
2017-12-06
Last updated
2019-03-21

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03364257. Inclusion in this directory is not an endorsement.

iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients (NCT03364257) · Clinical Trials Directory